All Access Articles |
- Dyne Therapeutics Completes Enrollment in ACHIEVE Trial expansion cohort for z-basivarsen | 2026-06-03 | PHARMACEUTICAL
- Dyne Therapeutics Reports $1.1B Cash Position | 2026-03-02 | UNITED STATES
- Dyne Therapeutics' Drug Granted Breakthrough Designation | 2025-08-04 | PHARMACEUTICAL
- Dyne Therapeutics' Dyne-101 Receives Breakthrough Designation | 2025-06-17 |